Short-term Versus Continuous Infusion: No Influence on Ifosfamide Side-chain Metabolism

By Boos J.   Silies H.   Hohenlochter B.   Jurgens H.   Blaschke G.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2417-2418

Elsevier

Access to resources Recommend Favorite

Comparison of Continuous Infusion and Bolus Administration of Ifosfamide in Children

By Boddy A.V.   Yule S.M.   Wyllie R.   Price L.   Pearson A.D.J.   Idle J.R.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 785-790

Elsevier

Access to resources Recommend Favorite

Metastatic secondary fibrosarcoma of bone responsive to repeated courses of ifosfamide and associated with hypoglycemia

By Bouttell Elaine S.   Rodger N. Wilson   Bramwell Vivien H.C.  

Sarcoma, Vol. 7, Iss. 2, 2003-06 ,pp. : 81-85

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics, Metabolism and Clinical Effect of Ifosfamide in Breast Cancer Patients

By Boddy A.V.   Proctor M.   Simmonds D.   Lind M.J.   Idle J.R.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 69-76

Elsevier

Access to resources Recommend Favorite

Chelation therapy by DFO-HOPO and 3,4,3-LIHOPO for injected Pu-238 and Am-241 in the rat: effect of dosage, time and mode of chelate administration

By Volf V.   Burgada R.   Raymond K. N.   Durbin P. W.  

International Journal of Radiation Biology, Vol. 70, Iss. 6, 1996-12 ,pp. : 765-772

Informa Healthcare

Access to resources Recommend Favorite